Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

The impact of COVID-19 vaccine hesitancy and resistance on the population of England

by Medical Finance
in Coronavirus
Study: Estimating the risk of hospitalisation and death in England
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A study conducted by the UK Health Security Agency has recently estimated the rate of hospitalization and death due to coronavirus disease 2019 (COVID-19) among unvaccinated persons residing in England. The study finds that a significant number of hospitalizations and deaths may happen if these unvaccinated populations become infected with the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is currently available on the medRxiv* preprint server.

Study: Estimating the risk of hospitalisation and death in England
Study: Estimating the risk of hospitalisation and death in England’s remaining unvaccinated population. Image Credit: Anishka Rozhkova/Shutterstock

Background

About 80% of the adult population in the UK have received at least two doses of the COVID-19 vaccines as of early 2022. In addition, about 67% of the population have received the third booster dose. Despite high vaccine coverage, a small but significant proportion of the UK population remains unvaccinated because of a lack of access or hesitancy to vaccination.

People’s hesitancy to receive COVID-19 vaccines is associated with various factors, including uncertainty about vaccine safety and efficacy, disbelief in government policies, and socio-cultural and religious beliefs. In addition, misinformation spread by anti-vaccination campaigns strongly discourages people from receiving COVID-19 vaccines.

In the current study, the scientists estimated the mortality rate in 2021 among unvaccinated people in England who have access to the COVID-19 vaccine but are hesitant to receive it. In addition, they have predicted the rates of hospitalization and mortality in the unvaccinated English population under two hypothetical situations. In one situation, they have assumed that no further vaccination has been done and unvaccinated people have become infected with SARS-CoV-2. In the other situation, they have assumed that most vaccine-resistant people have received full vaccination.

The study has focused on any deaths that occurred within 60 days of COVID-19 diagnosis. The analysis has been done by considering vaccination rates in five age groups, including 15-24 years, 25-44 years, 45-64 years, 65-74 years, and >75 years.    

Mortality rate among unvaccinated people

The mortality rate was calculated by considering the time when 90% of the two-dose vaccination administered by December 2021 was achieved. The analysis revealed that about 3500 deaths occurred in 2021 among unvaccinated people who had access to COVID-19 vaccination but refused to receive it because of vaccine hesitancy.

The study further estimated the number of deaths per day per million people in the vaccinated and unvaccinated populations to adjust for the significant size variation between vaccinated and unvaccinated populations. The findings revealed that the death rate is 2-8 times higher in the unvaccinated population compared to that in the vaccinated population.

Predicted hospitalization and mortality rate among unvaccinated people

The prediction analysis was conducted by considering that all of the remaining unvaccinated population in the UK got infected with SARS-CoV-2. The findings revealed that about 29,600 hospitalizations and 11,700 deaths could occur in the future if vaccine-hesitant people remain unvaccinated and contract SARS-CoV-2 infection, especially omicron infection.

Furthermore, the analysis predicted that the number of hospitalizations and deaths could be reduced to 19,500 and 5,300, respectively, if most vaccine-resistant people receive a COVID-19 vaccine.

Study significance

The study findings highlight that hesitancy to COVID-19 vaccination can significantly increase the rate of COVID-19-related hospitalizations and deaths in England. Importantly, the study predicts that the observed severity of COVID-19 could be reduced significantly if the majority of unvaccinated people, who are resistant to COVID-19 vaccination, agree to receive full vaccination.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Development of the one-step qualitative RT-PCR assay to detect SARS-CoV-2 Omicron (B.1.1.529) variant in respiratory specimens. Image Credit: anyaivanova/Shutterstock

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

by Medical Finance
May 20, 2022
0

A new preprint describes a single-step molecular diagnostic test for the presence of severe acute respiratory syndrome coronavirus 2...

Study: Modeling COVID-19 Vaccine Breakthrough Infections in Highly Vaccinated Israel - the effects of waning immunity and third vaccination dose. Image Credit: NEW-LIGHT-VISUALS / Shutterstock.com

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, researchers evaluated and modeled age-structured cases of severe acute respiratory...

Study: T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. Image Credit: Puwadol Jaturawutthichai/Shutterstock

Study finds T cell response mostly conserved against SARS-CoV-2 Omicron variant following infection or vaccination

by Medical Finance
May 20, 2022
0

The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown itself to be a very...

Study: COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness. Image Credit: Srarn Artrattanakul / Shutterstock.com

COVID-19 vaccination breakthrough infections in a real-world setting

by Medical Finance
May 20, 2022
0

The United States Food and Drug Administration (FDA) has authorized three vaccines against coronavirus disease 2019 (COVID-19), all of which...

Study: Comprehensive analysis of disease pathology in immunocompetent and immunocompromised hamster models of SARS-CoV-2 infection. Image Credit: CKA/Shutterstock

COVID-19 symptoms found to vary in different immune contexts

by Medical Finance
May 20, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers studied the kinetics of host response to severe acute...

Study: Detailed epitope mapping of SARS-CoV-2 nucleoprotein reveals specific immunoresponse in cats and dogs housed with COVID-19 patients. Image Credit: Ermolaev Alexander / Shutterstock.com

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

by Medical Finance
May 20, 2022
0

Despite only a few human-to-animal transmissions of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) that were initially reported, several animal...

Next Post
Study: SARS-CoV-2 Infections in Professional Orchestra and Choir Musicians – A Prospective Cohort Study. Image Credit: Skreidzeleu/Shutterstock

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

Study: NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells. Image Credit: Kateryna Kon/Shutterstock

Researchers discover mechanism behind SARS-CoV-2 entry into the brain

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies. Image Credit: Kateryna Kon/Shutterstock
    Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients
  • DNA sequence Gio.tto c40da62e4cd64a28bb62afe2ca60d1db 620x480
    Global human microbiome research dominated by highly developed countries
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply